LISANTI, Maria Chiara
 Distribuzione geografica
Continente #
NA - Nord America 104
EU - Europa 62
AS - Asia 14
AF - Africa 2
SA - Sud America 1
Totale 183
Nazione #
US - Stati Uniti d'America 104
IT - Italia 41
SG - Singapore 9
DE - Germania 8
SE - Svezia 3
CI - Costa d'Avorio 2
FI - Finlandia 2
IE - Irlanda 2
IN - India 2
PL - Polonia 2
RU - Federazione Russa 2
TR - Turchia 2
BR - Brasile 1
FR - Francia 1
GB - Regno Unito 1
PK - Pakistan 1
Totale 183
Città #
Chandler 22
Ashburn 15
Palermo 14
Singapore 7
Fairfield 6
New York 6
Aversa 5
Medford 4
Ludwigshafen am Rhein 3
San Diego 3
Santa Clara 3
Abidjan 2
Agrigento 2
Boardman 2
Bremen 2
Brzeg 2
Charlottesville 2
Dublin 2
Duezce 2
Helsinki 2
Messina 2
Naples 2
Osio Sotto 2
Princeton 2
Seattle 2
Cambridge 1
Dallas 1
Des Moines 1
Islamabad 1
Kitzingen 1
Kumar 1
Mehlingen 1
Monza 1
Norwalk 1
Pune 1
Rio de Janeiro 1
Tulsa 1
Turin 1
Wilmington 1
Totale 130
Nome #
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 83
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 80
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 25
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 18
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 14
Totale 220
Categoria #
all - tutte 1.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 1 0 0 0 10 0 0
2020/20216 0 0 0 0 0 0 0 0 5 0 0 1
2021/202246 10 6 2 1 0 8 0 3 1 7 0 8
2022/202364 5 5 3 7 2 10 8 10 7 0 0 7
2023/202462 0 3 4 7 0 22 9 2 0 6 0 9
2024/202525 2 9 14 0 0 0 0 0 0 0 0 0
Totale 220